This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Cognizant to Report Q2 Earnings: What's in Store for the Stock?
by Zacks Equity Research
CTSH's second-quarter 2025 performance is likely to have benefited from an expanding clientele and a robust pipeline that includes a favorable mix of new opportunities.
CTSH Rises 9% in a Month: Is the Stock a Must-Have for Your Portfolio?
by Zacks Equity Research
Cognizant gains from strong AI advancements and key partnerships, positioning the company for strong growth.
Cognizant to Report Q1 Earnings: What's in Store for the Stock?
by Zacks Equity Research
CTSH's first-quarter 2025 performance is likely to have reflected strength from an expanding clientele and a robust pipeline that includes a favorable mix of new opportunities.
CTSH Expands Clientele With OMRON Deal: Buy, Sell or Hold the Stock?
by Zacks Equity Research
Cognizant teams up with OMRON to transform manufacturing with IT-OT integration, offering smart solutions for enhanced productivity and sustainability.
Can Teradyne's Partnership With Analog Devices Push the Stock Higher?
by Zacks Equity Research
TER's robotics division collaborates with Analog Devices to transform semiconductor manufacturing with advanced robotics, AI, and edge-based automation.
Here's Why Teradyne is a Must-Buy Stock for Growth Oriented Investors
by Zacks Equity Research
TER stock is driven by strong growth in robotics, AI-powered automation and key partnerships, making it a top pick for growth-oriented investors in 2025.
Teradyne Stock Plunges 12% in the Past 6 Months: Buy the Dip or Wait?
by Zacks Equity Research
TER suffers from soft demand and macro challenges, but its growing robotics and AI focus are likely to drive a strong rebound.
What Makes Omron (OMRNY) a New Buy Stock
by Zacks Equity Research
Omron (OMRNY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
KYOCY or OMRNY: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
KYOCY vs. OMRNY: Which Stock Is the Better Value Option?
TTDKY or OMRNY: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
TTDKY vs. OMRNY: Which Stock Is the Better Value Option?
Omron Corp. (OMRNY) Q3 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Omron Corp. (OMRNY) delivered earnings and revenue surprises of 30.65% and 2.40%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Omron Corp. (OMRNY) is on the Move, Here's Why the Trend Could be Sustainable
by Zacks Equity Research
Omron Corp. (OMRNY) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
Here's Why Momentum in Omron Corp. (OMRNY) Should Keep going
by Zacks Equity Research
If you are looking for stocks that are well positioned to maintain their recent uptrend, Omron Corp. (OMRNY) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
Here's Why "Trend" Investors Would Love Betting on Omron Corp. (OMRNY)
by Zacks Equity Research
Omron Corp. (OMRNY) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
Here's What Could Help Omron Corp. (OMRNY) Maintain Its Recent Price Strength
by Zacks Equity Research
Omron Corp. (OMRNY) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
These Stocks Will Gain From a Boom is Health Technology
by Zacks Equity Research
The current demographic trend calls for development in technology associated to healthcare. Here are three stocks that can make the most from the health technology boom.